Status:

RECRUITING

Prospective Sinonasal Cancer Multi-institution Study

Lead Sponsor:

Mayo Clinic

Conditions:

Sinonasal Carcinoma

Eligibility:

All Genders

30-99 years

Brief Summary

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient qua...

Eligibility Criteria

Inclusion

  • Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
  • Patients with a diagnosis of sinonasal cancer
  • Patients undergoing treatment at Mayo Clinic

Exclusion

  • Healthy individuals
  • Unwilling to sign the informed consent

Key Trial Info

Start Date :

January 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2031

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04755855

Start Date

January 1 2021

End Date

January 1 2031

Last Update

October 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Prospective Sinonasal Cancer Multi-institution Study | DecenTrialz